ONCY

MKT CAP:$127M

Oncolytics Biotech Inc

Market Cap

$127M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$0.84-$0.14 (-14.61%)

Jun 5, 2026

52W High $1.4252W Low $0.36

Company Details

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for...

CEO

—

IPO Date

Nov 8, 1999

Website

oncolyticsbiotech.com

Key Metrics TTM (CAD)

Revenue

CAD 0

- YoY

Net Income

-CAD 35M

EPS (Diluted)

Free Cash Flow

-CAD 29M

Revenue / Share

CAD 0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 6, 2026

PENDING

Q1 2026

May 14, 2026

CAD 0

FY 2025

Mar 30, 2026

CAD 0

Q4 2025

Mar 30, 2026

CAD 0

Q3 2025

Nov 12, 2025

CAD 0

Revenue & Profitability (CAD)

Operating Cash Flow (CAD)

CapEx Spend (CAD)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (CAD)

OpEx Breakdown (CAD)

War Chest (CAD)

Shares Outstanding

Revenue Per Employee (CAD)

Revenue / Employee